0A8D.LSE Q/C Technologies, Inc.

Technology Computer Hardware London Exchange
- USD
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0A8D.LSE undervalued?

Graham number

The Graham number of Q/C Technologies, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Q/C Technologies, Inc. fundamental analysis

No fundamental analysis for Q/C Technologies, Inc. yet.

Q/C Technologies, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Q/C Technologies, Inc.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog …

Full company profile